Partnerships to Address COVID-19 Inequities

Sponsor
Duke University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05123729
Collaborator
(none)
200
2
50

Study Details

Study Description

Brief Summary

This study evaluates the impact of an intervention to increase COVID-19 prevention behaviors, including COVID-19 testing. The intervention will be developed through a crowdsourcing contest.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Crowdsourced campaign package
  • Behavioral: Standard information
N/A

Detailed Description

  1. The surge of COVID-19 cases has been accompanied by glaring racial disparities in COVID-19-related morbidity and mortality; disparities in outcomes have been most pronounced for African Americans who, despite comprising only 13% of the US population account for about 30% of all COVID-19 cases in states for which race-related data are reported. Infectious disease modelers, epidemiologists, and other public health experts believe that COVID-19 is here to stay and suggest that annual surges may persist through 2025 and beyond. With vaccine hesitancy and delay compromising our ability to attain herd immunity, the best means for controlling the spread of COVID-19 according to public health experts is mass adoption of the 3 Ws (Wear a mask, Wait 6 feet apart, and Wash your hands) and increasing awareness of one's status through testing. As such, non-pharmaceutical interventions (NPIs) are currently our best options for viral control and containment. NPIs that are community-driven and developed in collaboration with diverse partners, including community members, public health agencies, and researchers may offer an acceptable and effective approach to reducing COVID-19 transmission and addressing individual and socio-structural barriers that lead to worse COVID-19-related outcomes among African Americans. Our study goals are to use a crowdsourcing open call to identify exceptional ideas (e.g., messages, videos, communication and dissemination strategies) that promote COVID-19 testing and encourage the public to practice the 3 Ws, referred to as health-promotive behaviors.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Community-Academic Partnerships to Address COVID-19 Inequities Within African American Communities
Anticipated Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Sep 30, 2026
Anticipated Study Completion Date :
Sep 30, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Crowdsourced campaign package

The intervention will be developed through a crowdsourcing process, including an open call for submissions.

Behavioral: Crowdsourced campaign package
COVID-19 prevention intervention developed using a crowdsourcing process.

Active Comparator: Standard information

The control will be the provision of standard information (e.g., view standard informational videos promoting the adoption of health-protective behaviors and COVID-19 testing).

Behavioral: Standard information
Standard informational videos promoting the adoption of health-protective behaviors and COVID-19 testing

Outcome Measures

Primary Outcome Measures

  1. Number of participants enrolled as measured by enrollment log [Up to 3 years]

  2. Number of participants rating intervention as acceptable as measured by a post-intervention questionnaire [Up to 4 years]

  3. Change in the number of participants engaging in 1 or more of the 3 Ws as measured by participant report [up to 3 years; up to 38 months; up to 40 months]

    The 3Ws are defined as (1) Wearing a mask, (2) Waiting 6 feet apart, and (3) Washing your hands.

  4. Change in number of participants who stated that they would self-test for COVID-19 as measured by interview [up to 3 years; up to 38 months; up to 40 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • specific zip codes in North Carolina (specific zip codes to be determined)

  • no self-reported history of COVID-19 infection

  • have not tested within the past 14 days

Exclusion Criteria:
  • live outside of study area

  • under 18

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Duke University

Investigators

  • Principal Investigator: Tiarney Ritchwood, Duke University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT05123729
Other Study ID Numbers:
  • Pro00108968
First Posted:
Nov 17, 2021
Last Update Posted:
Jun 28, 2022
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 28, 2022